
Dr. Reddy's Laboratories Limited RDY
$ 13.23
-0.86%
Quarterly report 2022-Q1
added 06-27-2022
Dr. Reddy's Laboratories Limited Shares 2011-2026 | RDY
Annual Shares Dr. Reddy's Laboratories Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 166 M | 166 M | -52 M | -52 M | -52 M | -88 M | -88 M | 197 M | 302 M | 302 M | 211 M |
All numbers in INR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 302 M | -88 M | 92 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
10.2 M | - | -10.17 % | $ 12.2 K | ||
|
BioNTech SE
BNTX
|
244 M | $ 96.01 | -3.55 % | $ 27.2 B | ||
|
Burford Capital Limited
BUR
|
219 M | $ 5.42 | 3.04 % | $ 869 M | ||
|
I-Mab
IMAB
|
220 M | - | - | $ 866 M | ||
|
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | ||
|
Cerus Corporation
CERS
|
191 M | $ 2.63 | -3.49 % | $ 501 M | ||
|
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M | ||
|
AlloVir
ALVR
|
15.3 M | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
44.7 B | - | 2.54 % | $ 160 B | ||
|
Cardiff Oncology
CRDF
|
66.8 M | $ 1.67 | 1.21 % | $ 112 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
4.28 M | - | - | $ 269 M | ||
|
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
1.42 B | - | - | $ 96.9 B | ||
|
Edesa Biotech
EDSA
|
3.2 M | $ 15.84 | -1.68 % | $ 50.6 M | ||
|
Atreca
BCEL
|
38.6 M | - | -11.76 % | $ 5.79 M | ||
|
Berkeley Lights
BLI
|
68.9 M | - | -7.31 % | $ 87 M | ||
|
Calithera Biosciences
CALA
|
73.9 M | - | -10.95 % | $ 876 K | ||
|
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | ||
|
CymaBay Therapeutics
CBAY
|
106 M | - | - | $ 3.45 B | ||
|
ChemoCentryx
CCXI
|
69.9 K | - | - | $ 3.74 B | ||
|
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - | ||
|
Caladrius Biosciences
CLBS
|
8.33 M | - | -16.75 % | $ 25.8 M | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
4.31 M | $ 0.59 | -0.25 % | $ 2.54 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
21.6 M | - | - | $ 231 M | ||
|
Galapagos NV
GLPG
|
65.5 M | $ 28.54 | 0.4 % | $ 2.69 B | ||
|
Genmab A/S
GMAB
|
630 M | $ 27.28 | 0.89 % | $ 17 B | ||
|
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
166 M | $ 22.45 | 1.17 % | $ 3.72 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
9.27 M | - | -2.5 % | $ 5.88 M | ||
|
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
85.1 M | - | - | $ 2.18 B | ||
|
AIkido Pharma
AIKI
|
14.3 M | - | 1.93 % | $ 17.4 M | ||
|
Grifols, S.A.
GRFS
|
682 M | $ 8.24 | 0.12 % | $ 6.83 B | ||
|
Dynavax Technologies Corporation
DVAX
|
130 M | - | - | $ 2.02 B | ||
|
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
86.8 M | - | - | $ 28.6 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
1.65 M | $ 3.37 | 1.51 % | $ 5.55 M | ||
|
Eiger BioPharmaceuticals
EIGR
|
1.48 M | - | -9.21 % | $ 2.55 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
2.17 M | - | -5.68 % | $ 8.28 M | ||
|
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | ||
|
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | ||
|
Applied Therapeutics
APLT
|
84.2 M | - | - | $ 8.42 M | ||
|
ImmuCell Corporation
ICCC
|
9.03 M | $ 8.72 | - | $ 78.7 M | ||
|
Aptose Biosciences
APTO
|
2.45 M | - | -45.71 % | $ 1.2 M |